USHealthcare

Johnson & Johnson (JNJ)

US · Healthcare · Drug Manufacturers - General

$254.93+0.20%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$25.31B
Revenue YoY
+6.6%
Net profit
$5.53B
Profit YoY
-0.1%
EPS
$2.90
EPS estimate
$2.84
Net margin
21.9%

EPS came in at 2.90 against a street estimate of 2.84 — a beat of 2.1%.

Key statistics

Market cap
$617.78B
P/E
29.8
Forward P/E
22.0
P/B
7.27
Book value
$35.28
EPS (TTM)
$8.61
Dividend yield
2.05%
52-week high
$274.90
52-week low
$165.50
50-day MA
$245.20
200-day MA
$226.43
Beta
0.23

Analyst view

Analysts rate Johnson & Johnson a buy (11 buy, 13 hold, 0 sell out of 24) with an average price target of $271.05.

Shareholding

Insiders
0.05%
Institutions
76.83%

Largest institutional holders

FundStake
BlackRock Inc8.85%
Vanguard Capital Management, LLC6.50%
State Street Corp5.54%
Vanguard Portfolio Management, LLC2.64%
JPMorgan Chase & Co2.62%
Geode Capital Management, LLC2.46%
Morgan Stanley - Brokerage Accounts1.86%
State Farm Mutual Automobile Ins Co1.31%

Recent filings & reports

DocumentDate
Reg FD disclosure · Q3 20262026-07-29
Reg FD disclosure · Q3 20262026-07-28
Quarterly report · Q2 20262026-07-23
Results announced · Q3 20262026-07-15
Shareholder vote results · Q2 20262026-04-28
Quarterly report · Q1 20262026-04-22
Proxy statement · Q1 20262026-03-11
Annual report FY20252026-02-11

Readable in the app.

Corporate actions

ActionDetailDate
Dividend$1.34 / share
ex-date Aug 25, 2026 · pay Sep 8, 2026
2026-08-25
Dividend$1.34 / share
ex-date May 26, 2026 · pay Jun 9, 2026
2026-05-26
Dividend$1.30 / share
ex-date Feb 24, 2026 · pay Mar 10, 2026
2026-02-24
Dividend$1.30 / share
ex-date Nov 25, 2025 · pay Dec 9, 2025
2025-11-25
Dividend$1.30 / share
ex-date Aug 26, 2025 · pay Sep 9, 2025
2025-08-26

Deals & corporate news

AnnouncementDate
Completed acquisition of Firefly Bio and strategic collaboration with Sail
Johnson & Johnson completed its acquisition of Firefly Bio and entered a strategic collaboration with Sail Biomedicines on July 29, 2026. These transactions will significantly reduce the com
2026-07-29
Intent to separate Orthopaedics business announced
Johnson & Johnson announced third-quarter 2025 financial results on October 14, 2025. The company reported sales and earnings for the quarter ended September 28, 2025, along with nine-month
2025-10-14

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Johnson & Johnson — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-08-05.